Skip to content
healthcare.dev

Occuloplex G

NDC 43857-0513, Euphrasia Officinalis, Ginkgo Biloba, Petroselinum Sativum, Vaccinium Myrtillus, Ascorbicum Acidum, Spigelia Anthelmia, Eye (Suis), Germanium Sesquioxide, Ubidecarenonum, Aurum Metallicum, Bryonia (Alba), Hepar Sulphuris Calcareum, Phosphorus, Ruta Graveolens, Sulphur, Lithium Metallicum, liquid, from BioActive Nutritional, Inc..

Product NDC
43857-0513
Status
Listed
Labeler
BioActive Nutritional, Inc.
Dosage form
LIQUID
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
UNAPPROVED HOMEOPATHIC
Application
—
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/43857-0513 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • EUPHRASIA STRICTA3 [hp_X]/mL
  • GINKGO3 [hp_X]/mL
  • PETROSELINUM CRISPUM WHOLE3 [hp_X]/mL
  • BILBERRY3 [hp_X]/mL
  • ASCORBIC ACID6 [hp_X]/mL
  • SPIGELIA ANTHELMIA WHOLE6 [hp_X]/mL
  • SUS SCROFA EYE6 [hp_X]/mL
  • GERMANIUM SESQUIOXIDE8 [hp_X]/mL
  • UBIDECARENONE8 [hp_X]/mL
  • GOLD12 [hp_X]/mL
  • BRYONIA ALBA ROOT12 [hp_X]/mL
  • CALCIUM SULFIDE12 [hp_X]/mL
  • PHOSPHORUS12 [hp_X]/mL
  • RUTA GRAVEOLENS FLOWERING TOP12 [hp_X]/mL
  • SULFUR12 [hp_X]/mL
  • LITHIUM14 [hp_X]/mL

Pharmacologic classes

Allergens [CS]; Ascorbic Acid [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Mood Stabilizer [EPC]; Standardized Chemical Allergen [EPC]; Vitamin C [EPC]

Package NDCNDC-11Package
43857-0513-14385705130130 mL in 1 BOTTLE, DROPPER (43857-0513-1)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 43857-0513 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/43857-0513 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 43857-0513. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.